NLRP3 and type 2 diabetes mellitus: Despite increasing evidence of the relationship between the NLRP3 inflammasome, mitochondrial dysfunction and oxidative stress, and of their participation in type 2 diabetes physiopathology, therapeutic strategies to combat type 2 diabete, which target NLRP3 inflammasome, are yet to be consolidated.